Telomere maintenance in childhood primitive neuroectodermal brain tumors

Neuro-Oncology

Volumn 6, Issue 1, 2004, Pages 1-8

  Didiano, Domenico ^b   Shalaby, Tarek ^b   Lang, Doris ^a   Grotzer, Michael A ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIGALLOCATECHIN GALLATE; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ADOLESCENT; ADULT; BRAIN TUMOR; CANCER THERAPY; CELL PROLIFERATION; CEREBELLUM; CHILD; CHILDHOOD CANCER; CHROMOSOME SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DNA DETERMINATION; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROECTODERM TUMOR; PATHOGENESIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SAMPLING; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR CELL LINE; UPREGULATION;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CATECHIN; CELL LINE, TUMOR; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETUS; HUMANS; INFANT; MALE; MIDDLE AGED; NEUROECTODERMAL TUMORS, PRIMITIVE; TELOMERASE; TELOMERE;

EID: 0942298814     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851703000176     Document Type: Review

References (51)

1. Bieche, I., Nogues, C., Paradis, V., Olivi, M., Bedossa, P., Lidereau, R., and Vidaud, M. (2000) Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin. Cancer Res. 6, 452-459.
2. Blackburn, E.H. (1991) Structure and function of telomeres. Nature 350, 569-573.
3. Bosoy, D., Peng, Y., Mian, I.S., and Lue, N.F. (2003) Conserved N-terminal motifs of telomerase reverse transcriptase required for ribonucleoprotein assembly in vivo. J. Biol. Chem. 278, 3882-3890.
4. Bryan, T.M., and Cech, T.R. (1999) Telomerase and the maintenance of chromosome ends. Curr. Opin. Cell Biol. 11, 318-324.
5. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S., and Reddel, R.R. (1995) Telomere elongation in immortal human cells without detectable telomerase activity. Embo J. 14, 4240-4248.
6. Bustin, S.A. (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25, 169-193.
7. Cao, Y., and Cao, R. (1999) Angiogenesis inhibited by drinking tea. Nature 398, 381.
8. DeMasters, B.K., Markham, N., Lillehei, K.O., and Shroyer, K.R. (1997) Differential telomerase expression in human primary intracranial tumors. Am. J. Clin. Pathol. 107, 548-554.
9. Falchetti, M.L., Larocca, L.M., and Pallini, R. (2002) Telomerase in brain tumors. Childs Nerv. Syst. 18, 112-117.
10. Feng, J., Funk, W.D., Wang, S.-S., Weinrich, S.L., Avilion, A.A., Chiu, C.-P., Adams, R.R., Chang, E., Allsopp, R.C., Yu, J., Le, S., West, M.D., Harley, C.B., Andrews, W.H., Greider, C.W., and Villeponteau, B. (1995) The RNA component of human telomerase. Science 269, 1236-1241.
11. Folini, M., Colella, G., Villa, R., Lualdi, S., Daidone, M.G., and Zaffaroni, N. (2000) Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells. J. Invest. Dermatol. 114, 259-267.
12. Fujiki, H., Suganuma, M., Okabe, S., Sueoka, E., Sueoka, N., Fujimoto, N., Goto, Y., Matsuyama, S., Imai, K., and Nakachi, K. (2001) Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat. Res. 480-481, 299-304.
13. Fujiki, H., Suganuma, M., Okabe, S., Sueoka, E., Suga, K., Imai, K., Nakachi, K., and Kimura, S. (1999) Mechanistic findings of green tea as cancer preventive for humans. Proc. Soc. Exp. Biol. Med. 220, 225-228.
14. Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R., and Mathieu, C. (2001) An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression. Methods 25, 386-401.
15. Grosso, R., and Schiffer, D. (1998) Prognostic significance of telomerase in brain tumors. Crit. Rev. Neurosurg. 8, 244-247.
16. Grotzer, M.A., Eggert, A., Zuzak, T.J., Janss, A.J., Marwaha, S., Wiewrodt, B.R., Ikegaki, N., Brodeur, G.M., and Phillips, P.C. (2000) Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. Oncogene 19, 4604-4610.
17. Grotzer, M.A., Hogarty, M.D., Janss, A.J., Liu, X., Zhao, H., Eggert, A., Sutton, L.N., Rorke, L.B., Brodeur, G.M., and Phillips, P.C. (2001) MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin. Cancer Res. 7, 2425-2433.
18. Gurney, J.G., Smith, M.A., and Bunin, G.R. (1999) CNS and miscellaneous intracranial and intraspinal neoplasms. In: Ries, L.A,G., Smith, M.A., Gurney, J.G., Linet, M., Tamra, T., Young, J.L. and Bunin, G.R. (Eds.), Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, Md.: National Institutes of Health.
19. Hanahan, D., and Weinberg, R.A. (2000) The hallmarks of cancer. Cell 100, 57-70.
20. Harrison, R.J., Gowan, S.M., Kelland, L.R., and Neidle, S. (1999) Human telomerase inhibition by substituted acridine derivatives. Bioorg. Med. Chem. Lett. 9, 2463-2468.
21. Hasaniya, N., Youn, K., Xu, M., Hernaez, J., and Dashwood, R. (1997) Inhibitory activity of green and black tea in a free radical-generating system using 2-amino-3-methylimidazo[4,5-f]quinoline as substrate. Jpn. J. Cancer Res. 88, 553-558.
22. Hayakawa, N., Nozawa, K., Ogawa, A., Kato, N., Yoshida, K., Akamatsu, K., Tsuchiya, M., Nagasaka, A., and Yoshida, S. (1999) Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro. Biochemistry 38, 11501-11507.
23. Heid, C.A., Stevens, J., Livak, K.J., and Williams, P.M. (1996) Real time quantitative PCR. Genome Res. 6, 986-994.
24. Henson, J.D., Neumann, A.A., Yeager, T.R., and Reddel, R.R. (2002) Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610.
25. Hiraga, S., Ohnishi, T., Izumoto, S., Miyahara, E., Kanemura, Y., Matsumura, H., and Arita, N. (1998) Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res. 58, 2117-2125.
26. Huber, H., Eggert, A., Janss, A.J., Wiewrodt, R., Zhao, H., Sutton, L.N., Rorke, L.B., Phillips, P.C., and Grotzer, M.A. (2001) Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas. Eur. J. Cancer 37, 2064-2072.
27. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L., and Shay, J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
28. Kinjo, J., Nagao, T., Tanaka, T., Nonaka, G., Okawa, M., Nohara, T., and Okabe, H. (2002) Activity-guided fractionation of green tea extract with anti proliferative activity against human stomach cancer cells. Biol. Pharm. Bull. 25, 1238-1240.
29. Langford, L.A., Piatyszek, M.A., Xu, R., Schold, S.C., Jr., and Shay, J.W. (1995) Telomerase activity in human brain tumours. Lancet 346, 1267-1268.
30. Langford, L.A., Piatyszek, M.A., Xu, R., Schold, S.C., Jr., Wright, W.E., and Shay, J.W. (1997) Telomerase activity in ordinary meningiomas predicts poor outcome. Human Pathol. 28, 416-420.
31. Lee, M.J., Wang, Z.Y., Li, H., Chen, L., Sun, Y., Gobbo, S., Balentine, D.A., and Yang, C.S. (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4, 393-399.
32. Liu, J., Guo, L., Luo, Y., Li, J.W., and Li, H. (2000) All trans-retinoic acid suppresses in vitro growth and down-regulates LIF gene expression as well as telomerase activity of human medulloblastoma cells. Anticancer Res. 20, 2659-2664.
33. Lyu, S.Y., Choi, S.H., and Park, W.B. (2002) Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53. Arch. Pharm. Res. 25, 93-101.
34. Mu, J., and Wei, L.X. (2002) Telomere and telomerase in oncology. Cell Res., 12, 1-7.
35. Naasani, I., Seimiya, H., and Tsuruo, T. (1998) Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem. Biophys. Res. Commun. 249, 391-396.
36. Naasani, I., Seimiya, H., Yamori, T., and Tsuruo, T. (1999) FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Res. 59, 4004-4011.
37. Naasani, I., Oh-Hashi, F., Oh-Hara, T., Feng, W.Y., Johnston, J., Chan, K., and Tsuruo, T. (2003) Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res. 63, 824-830.
38. Nakagawa, K., and Miyazawa, T. (1997) Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J. Nutr. Sci. Vitaminol. (Tokyo) 43, 679-684.
39. Neumann, A.A., and Reddel, R.R. (2002) Telomere maintenance and cancer - look, no telomerase. Nature Rev. Cancer 2, 879-884.
40. Read, M.A., Wood, A.A., Harrison, J.R., Gowan, S.M., Kelland, L.R., Dosanjh, H.S., and Neidle, S. (1999) Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: Structure-activity relationships. J. Med. Chem. 42, 4538-4546.
41. Sano, T., Asai, A., Mishima, K., Fujimaki, T., and Kirino, T. (1998) Telomerase activity in 144 brain tumours. Br. J. Cancer 77, 1633-1637.
42. Shay, J.W., and Bacchetti, S. (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791.
43. Simon, M., Park, T.W., Leuenroth, S., Hans, V.H., Loning, T., and Schramm, J. (2000) Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression. J. Neurosurg. 92, 832-840.
44. Strahl, C., and Blackburn, E.H. (1996) Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol. Cell. Biol. 16, 53-65.
45. Suganuma, M., Okabe, S., Sueoka, N., Sueoka, E., Matsuyama, S., Imai, K., Nakachi, K., and Fujiki, H. (1999) Green tea and cancer chemoprevention. Mutat. Res. 428, 339-344.
46. Wadhwa, R., Colgin, L., Yaguchi, T., Taira, K., Reddel, R.R., and Kaul, S.C. (2002) Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivo. Cancer Res. 62, 4434-4438.
47. White, L.K., Wright, W.E., and Shay, J.W. (2001) Telomerase inhibitors. Trends Biotechnol. 19, 114-120.
48. Yang, C.S., Chen, L., Lee, M.J., and Landau, J.M. (1996) Effects of tea on carcinogenesis in animal models and humans. Adv. Exp. Med. Biol. 401, 51-61.
49. Yang, C.S., and Wang, Z.Y. (1993) Tea and cancer. J. Natl. Cancer Inst. 85, 1038-1049.
50. Yokoyama, Y., Takahashi, Y., Shinohara, A., Lian, Z., Wan, X., Niwa, K., and Tamaya, T. (1998) Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res. 58, 5406-5410.
51. Zuzak, T.J., Steinhoff, D.F., Sutton, L.N., Phillips, P.C., Eggert, A., and Grotzer, M.A. (2002) Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma. Eur. J. Cancer 38, 83-91.